Tag: China
Sun Pharma makes an entry into generic pharma market in Mainland...
Sun Pharma and China Medical System Holdings have entered into licensing agreement for generic products in Mainland China..............
Cipla EU & Jiangsu Acebright enter into a joint venture
According to the agreement, Cipla EU will hold an 80% stake and Acebright will hold a 20% stake in it for a combined investment of USD 30mn. Upon incorporation, the JV Co will set up a manufacturing facility for local manufacture of respiratory products.............
Scientists record first ever presence of Octopus in Narmada estuary
The presence of Octopus species has been monitored in the bag net (10 mm cod end mesh size) fish catch at Bhadbhut village in the month of December 2018...........
Chinese biotech revolution to have highest impact globally in 2019, says...
The government-supported Chinese biotech revolution will bring forth many Chinese drug developers to compete with well-established multinational drug companies...............
India seeks greater market access for agri & pharma products in...
The top commerce ministry officials of India and China discussed the various issues related to commercial transactions between two nations including widening trade deficit...……….
Syringes & cannulas market growth remains concentrated in triumvirate of US,...
The study by Fact.MR has found that the U.S., India, and China collectively account for nearly 45 percent of the overall syringes and cannulas market...………..
India’s rice export to China gets major boost
Five more rice mills have been cleared for exporting non-basmati rice, from India to China, taking the total to 24 rice mills...………..
AstraZeneca well placed to use Medtech to expand in Chinese healthcare...
The Chinese Internet giants will develop smart health services, AI-assisted screening and diagnosis tools for the British pharma giant...……….
Asia pacific infusion therapy device market notches strong growth
In this exclusive contributory column, Andrew M. Ignatov and Sean Collins while sharing their insights explain how the infusion therapy will continue to be one of the leading factors in making the expansion of healthcare in Asia Pacific countries viable, effective and efficient...…………….
US-China trade war offers window of opportunity for Indian pharma sector
As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..